Related Experiment Video
Updated: Aug 30, 2025
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
A LRRK2/dLRRK-mediated lysosomal pathway that contributes to glial cell death and DA neuron survival
Linfang Wang1, Honglei Wang1, Shuanglong Yi1
1School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Abstract:
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial and sporadic Parkinson's disease. A plethora of evidence has indicated a role for LRRK2 in endolysosomal trafficking in neurons, while LRRK2 function in glia, although highly expressed, remains largely unknown. Here, we present evidence that LRRK2/dLRRK mediates a lysosomal pathway that contributes to glial cell death and the survival of dopaminergic (DA) neurons. LRRK2/dLRRK knockdown in the immortalized microglia or flies results in enlarged and swelling lysosomes fewer in number. These lysosomes are less mobile, wrongly acidified, exhibit defective membrane permeability and reduced activity of the lysosome hydrolase cathepsin B. In addition, LRRK2/dLRRK depletion causes glial apoptosis, DA neurodegeneration, and locomotor deficits in an age-dependent manner. Taken together, these findings demonstrate a functional role of LRRK2/dLRRK in regulating the glial lysosomal pathway; deficits in lysosomal biogenesis and function linking to glial apoptosis potentially underlie the mechanism of DA neurodegeneration, providing insights on LRRK2/dLRRK function in normal and pathological brains.
Insights
Leucine-rich repeat kinase 2 (LRRK2) regulates glial lysosomal pathways crucial for dopaminergic neuron survival. Impaired LRRK2 function leads to lysosomal defects, glial cell death, and neurodegeneration in Parkinson's disease models.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are a primary genetic cause of Parkinson's disease.
- LRRK2's role in neuronal endolysosomal trafficking is established, but its function in glia remains unclear.
Purpose of the Study:
- To investigate the function of LRRK2 in glial cells and its contribution to neurodegeneration.
- To elucidate the role of LRRK2 in glial lysosomal pathways.
Main Methods:
- LRRK2/dLRRK knockdown in immortalized microglia and Drosophila models.
- Analysis of lysosomal morphology, acidification, membrane permeability, and cathepsin B activity.
- Assessment of glial apoptosis, dopaminergic neuron survival, and locomotor activity.
Main Results:
- LRRK2/dLRRK depletion resulted in enlarged, swollen, and less mobile lysosomes with impaired acidification and cathepsin B activity.
- Knockdown led to glial apoptosis, dopaminergic neurodegeneration, and age-dependent locomotor deficits.
- These findings highlight LRRK2's role in maintaining glial lysosomal function.
Conclusions:
- LRRK2/dLRRK is essential for regulating the glial lysosomal pathway, impacting lysosomal biogenesis and function.
- Defects in this pathway contribute to glial apoptosis and dopaminergic neurodegeneration, offering insights into Parkinson's disease mechanisms.
Related Concept Videos
01:22Lysosomal Hydrolases
01:00Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...